Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin in Early Staphylococcal Prosthetic Joint Infections
NCT00423982Phase 4Unknown
- Sponsor
- Oslo University Hospital
- Start
- Apr 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin in prosthetic joint infection (PJI), sponsored by Oslo University Hospital. Status: unknown.
02
Drugs
rifampicin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT00423982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423982.